Neoprobe completes sale of device business; plans to change name
In a deal that marks its transformation to a pure-play radiopharmaceutical company, Neoprobe (NYSE Amex:NEOP) … Continue reading Neoprobe completes sale of device business; plans to change name
0 Comments